FAQ
Safeguarding Clinical Trials in Africa: The Critical Role of Biosafety and Biosecurity
Recent Posts 8 August 2025 – Harare, Zimbabwe / Cape Town & Durban, South Africa – African clinical research institutions, in partnership with global collaborators, have launched a Phase 1 clinical trial to evaluate a novel HIV vaccine candidate, GRAdHIVNE1. The trial is being conducted by Mutala Trust (Zimbabwe), the Desmond Tutu Health Foundation (DTHF), and […]
African Research Institutions Launch Phase 1 HIV Vaccine Clinical Trial in Southern Africa
Recent Posts 8 August 2025 – Harare, Zimbabwe / Cape Town & Durban, South Africa – African clinical research institutions, in partnership with global collaborators, have launched a Phase 1 clinical trial to evaluate a novel HIV vaccine candidate, GRAdHIVNE1. The trial is being conducted by Mutala Trust (Zimbabwe), the Desmond Tutu Health Foundation (DTHF), and […]